uk-plab-1 MCQ (SBA): Diabetic chronic kidney disease therapy

Instant feedback + full explanation. One question, done properly.

ModerateNephrologyDiabetic chronic kidney disease therapyuk-plab-1

A 74 year old woman with chronic kidney disease stage 3 has an eGFR of 48 mL/min/1.73 m² and an albumin creatinine ratio of 8 mg/mmol. She has type 2 diabetes. According to NICE guidance on diabetes and CKD, which drug class should be added to her existing ACE inhibitor to reduce renal and cardiovascular risk if there are no contraindications?

Educational content. Not a substitute for clinical judgement or local policy.

uk-plab-1 MCQ: Diabetic chronic kidney disease therapy — Answer & Expl